InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,180.74
(
1.03%
)
US TECH 100
17,599.60
(
1.04%
)
Dow Jones
38,852.27
(
0.46%
)
Brent Oil
83.46
(
-0.02%
)
Bitcoin
63,702.21
(
0.85%
)
Post# of 220
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

PoemStone

Send PM Follow Ignore
Followers 864
Posts 27574
Boards Moderated 1
Alias Born 11/05/2010

PoemStone

Re: goarmy123 post# 158

Friday, 01/27/2012 10:12:17 PM

Friday, January 27, 2012 10:12:17 PM

Post# of 220
DOTD Selection. PFE. 1-27-2012 FDA Approves Inlyta
The U.S. Food and Drug Administration has approved Inlyta (axitinib) to treat patients with advanced kidney cancer (renal cell carcinoma) who have not responded to another drug for this type of cancer.

http://www.drugs.com/inlyta.html

Several DD sheets on HOSS TRACKZ.
investorshub.advfn.com/boards/board.aspx?board_id=23067

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up